For example, a pathogenic variant in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein causing cystic fibrosis has been considered a target for a potential therapy with sodium phenylbutyrate. The gene discussed is CFTR; the disease is cystic fibrosis.